XML 77 R63.htm IDEA: XBRL DOCUMENT v3.26.1
Reverse Recapitalization (Tables)
12 Months Ended
Dec. 31, 2025
Reverse Recapitalization  
Schedule of reconciliation of business combination to statement of cash flows

The following table reconciles the elements of the Business Combination to the consolidated statements of cash flows for the year ended December 31, 2025:

  ​ ​ ​

  ​ ​ ​

Cash-trust and cash, net of redemptions

  ​ ​ ​

$

243,066,977

Add: proceeds from issuance of shares from PIPE investors

49,500,000

Less: transaction costs and professional fees, paid

 

(22,305,729)

Net proceeds from the Business Combination

$

270,261,248

Schedule of reconciliation of common and exchangeable shares

TEDI existing shares at closing date:

  ​ ​ ​

Preferred Series A shares

200,592

Common shares

784,831

Total TEDI shares at closing date

985,423

Total TEDI shares at closing date - recasted

44,051,295

Conversion of convertible notes to common shares

3,977,517

Issuance of shares to PIPE investors

5,000,000

Issuance of shares to HCM II

28,742,610

Total recapitalized common shares at December 31, 2025

81,771,422

TEDI existing exchangeable shares at closing date:

  ​ ​ ​

Preferred exchangeable shares

6,200

Common exchangeable shares

 

530,924

Total TEDI exchangeable shares at closing date

537,124

Total TEDI exchangeable shares at closing date - recasted

24,011,017

Conversion of preferred exchangeable shares to exchangeable shares

277,158

Conversion of common exchangeable shares to exchangeable shares

23,733,859

Total recapitalized exchangeable shares at December 31, 2025

24,011,017

Schedule of transaction expenses

  ​ ​ ​

December 31, 2025

Professional fees

$

14,324,981

Legal expenses

7,980,748

Total transaction costs

$

22,305,729